AK
Alden Klarer
Physician · University of Louisville School of Medicine
Credentials: · · ·
History
- 2021–Present
Research
Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer
Molecular Cancer Therapeutics · 2013 · 239 citations
Cell Death and Disease · 2014 · 164 citations
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism
Cancer & Metabolism · 2014 · First of 9 authors · 87 citations
- JC
8 papers
- ST
8 papers
- DM
2 papers
- DK
1 paper · 1 as a resident
- HF
1 paper
1 paper
- MR
1 paper
- RM
1 paper · 1 as a resident
Grants
- 2009–2015
Y-Family DNA Polymerases and Cellular Responses to Benzo[a]pyrene
National Institute of Environmental Health Sciences · F30
Contact PI · $171K · University of Louisville